Literature DB >> 15851695

Cardiovascular risk in patients with type 2 diabetes.

Malvinder Parmar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15851695      PMCID： PMC557047          DOI： 10.1503/cmaj.1041725

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

2.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

3.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

4.  Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis.

Authors:  Lauren C Brown; Jeffrey A Johnson; Sumit R Majumdar; Ross T Tsuyuki; Finlay A McAlister
Journal:  CMAJ       Date:  2004-11-09       Impact factor: 8.262

Review 5.  1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.

Authors:  S Meltzer; L Leiter; D Daneman; H C Gerstein; D Lau; S Ludwig; J F Yale; B Zinman; D Lillie
Journal:  CMAJ       Date:  1998       Impact factor: 8.262

6.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

Authors:  Rory Collins; Jane Armitage; Sarah Parish; Peter Sleigh; Richard Peto
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.